Stock 688131 SHANGHAI HAOYUAN CHEMEXPRESS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Shanghai Haoyuan Chemexpress Co., Ltd.

Equities

688131

CNE1000051J4

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 27/05/2024 BST 		5-day change 1st Jan Change
29.63 CNY +0.44% Intraday chart for Shanghai Haoyuan Chemexpress Co., Ltd. -7.49% -43.08%
04-29 Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-25 Haoyuan Chemexpress to Issue 822 Million Yuan Worth of Convertible Bonds MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Haoyuan Chemexpress to Issue 822 Million Yuan Worth of Convertible Bonds
MT
Haoyuan Chemexpress to Raise Subsidiary's Capital by 200 Million Yuan
MT
Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Shanghai Haoyuan Chemexpress Co., Ltd.(XSSC:688131) added to S&P Global BMI Index
CI
Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Shanghai Haoyuan Chemexpress Shareholders Plan to Unload Company's Stakes
CI
Shanghai Haoyuan Chemexpress Co., Ltd.(SHSE:688131) dropped from Shanghai Stock Exchange Health Care Sector Index
CI
Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Haoyuan Chemexpress to Build Drug Center for 500 Million Yuan
MT
Haoyuan Chemexpress Logs 1.4% Rise in 2022 Profit
MT
Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Haoyuan Chemexpress Raising 50 Million Yuan From Controlling Shareholder to Buy Local Drugmaker
MT
Shanghai Haoyuan Chemexpress Co., Ltd. announced that it has received CNY 49.999962 million in funding from Shanghai Anxu Information Technology Co., Ltd., Shanghai Yuanmeng Enterprise Management Consulting Partnership (Limited Partnership), Ningbo Jiusheng Innovation Pharmaceutical Technology Co., Ltd, Shanghai Yuanli Enterprise Management Partnership
CI
Shanghai Haoyuan Chemexpress Co., Ltd. completed the acquisition of 2Y-Chem, Ltd. from Ningbo Jiusheng Innovative Pharmaceutical Technology Co., Ltd., Qidong Yuanli Enterprise Management Consulting Partnership (Limited Partnership), Shanghai Yuanmeng Enterprise Management Consulting Partnership (Limited Partnership) and WANG YUAN.
CI
Shanghai Haoyuan Chemexpress Co., Ltd.(SHSE:688131) added to Shanghai Stock Exchange Health Care Sector Index
CI
Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Shanghai Haoyuan Chemexpress Co., Ltd.(SHSE:688131) added to Shanghai Stock Exchange A Share Index
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688131 Stock
  4. News Shanghai Haoyuan Chemexpress Co., Ltd.